Clinical Trials on Males With Benign Prostatic Hyperplasia Symptoms in Netherlands

Total 85 results

GlaxoSmithKline

Completed

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Elesta S.R.L.

Completed

Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction

Prostatic Hyperplasia, Benign

Netherlands
Maastricht University Medical Center
Yamanouchi

Completed

Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Netherlands
Astellas Pharma Europe B.V.

Completed

EC905 Pharmacokinetic Profile Study

Healthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1

Netherlands
Boston Scientific Corporation

Completed

Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH

Benign Prostatic Hyperplasia

United Kingdom, Germany, Austria, Spain, Belgium, France, Italy, Netherlands, Switzerland
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

Italy, France, Belgium, Australia, Greece, Austria, Netherlands, Germany, Mexico, Poland
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
AEterna Zentaris

Completed

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

Netherlands, Belarus, Bulgaria, Czech Republic, France, Germany, Italy, Macedonia, The Former Yugoslav Republic of, Romania, United Kingdom
Leiden University Medical Center

Completed

Effect of Deep BLock on Intraoperative Surgical Conditions (BLISS)

Renal Disease | Prostate Hypertrophy

Netherlands
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
The European Uro-Oncology Group
Centre for Human Drug Research, Netherlands

Completed

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Prostate Cancer Metastatic

Netherlands
Erasmus Medical Center

Recruiting

Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics (LUTRAC)

Prostate Cancer Metastatic

Netherlands
Amsterdam UMC, location VUmc

Active, not recruiting

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy (RaRe)

Prostate Cancer Metastatic to Bone

Netherlands
Pfizer

Completed

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Prostatic Hyperplasia

Netherlands, Czech Republic, Slovakia
The Netherlands Cancer Institute
Bayer

Completed

Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 (ROTOR)

Bone Metastases | Prostate Cancer Metastatic

Netherlands
Radboud University Medical Center
ABX advanced biochemical compounds GmbH; Radboud Translational Medicine

Recruiting

F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer (PROPER-ABX)

Prostate Cancer Recurrent

Netherlands
Clinical Research Office of the Endourological...

Active, not recruiting

Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device

Prostate Cancer

Netherlands
Radboud University Medical Center

Not yet recruiting

Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer (QmpMRI)

Prostate Cancer

Netherlands
The European Uro-Oncology Group
Centre for Human Drug Research, Netherlands

Completed

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute

Recruiting

Tracer-Guided Surgery for Recurrent Prostate Cancer (Trace-II)

Prostate Cancer

Netherlands
Canisius-Wilhelmina Hospital
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients (PSMA-SELECT)

Prostate Cancer | Prostate Cancer Metastatic | Lymph Node Metastases

Netherlands
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
Radboud University Medical Center

Completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity (LEANDOC)

Breast Cancer | Metastatic Castration-resistant Prostate Carcinoma

Netherlands
ABX advanced biochemical compounds GmbH

Active, not recruiting

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Prostate Cancer | Prostate Cancer Recurrent

United States, Netherlands, Switzerland
UMC Utrecht

Recruiting

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide (PET-MaN-enza)

Prostate Cancer

Netherlands
Radboud University Medical Center
Advanced Accelerator Applications; Prostaatkankerstichting

Recruiting

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer (Bullseye)

Prostate Cancer

Netherlands, Cyprus
Roderick van den Bergh

Recruiting

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer (PET-MaN)

Prostate Cancer

Netherlands
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
Astellas Pharma Inc

Completed

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

France, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
Radboud University Medical Center

Active, not recruiting

Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients (DETECT)

Prostate Cancer | Lymph Node Metastases

Netherlands
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
Comprehensive Cancer Centre The Netherlands

Recruiting

High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)

Prostate Cancer | Prostate Adenocarcinoma

Netherlands
Radboud University Medical Center
Astellas Pharma Inc; Catharina Ziekenhuis Eindhoven; Canisius-Wilhelmina Hospital

Unknown

Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI (MAGNIFY)

Prostate Cancer | Lymph Node Metastases

Netherlands
Saving Patients' Lives Medical B.V.
Radboud University Medical Center; ABX-CRO advanced pharmaceutical services... and other collaborators

Recruiting

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Prostate Cancer | Metastasis | Prostatectomy

Germany, Belgium, Netherlands, Switzerland
Radboud University Medical Center
Bayer

Completed

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Bone Metastases | Castrate Resistant Prostate Cancer

Netherlands
Rijnstate Hospital

Withdrawn

Stellate Ganglion Block for Hot Flushes in Men Treated With ADT

Prostate Cancer

Netherlands
University Medical Center Groningen
Dutch Cancer Society

Recruiting

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)

Prostate Cancer

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. (pro-SWAP)

Prostate Cancer | Infection | Complication

Netherlands
Erasmus Medical Center
Sanofi

Active, not recruiting

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) (CABA-V7)

Metastatic Prostate Cancer | Circulating Tumor Cell

Netherlands
Ipsen

Completed

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer (TRIPTOCARE LT)

Advanced Prostate Cancer

Netherlands, France, United Kingdom, Denmark, Latvia, Lithuania, Romania
Thomas Zilli

Active, not recruiting

Hypofractionated Radiation Therapy in Prostate Cancer

Malignant Neoplasm of Prostate | Local Disease

Netherlands, Israel, Switzerland, Spain, Belgium, Finland, Portugal, Turkey
European Organisation for Research and Treatment...

Completed

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Prostate Cancer

Belgium, Poland, Italy, Austria, France, Denmark, Netherlands, United Kingdom, Israel, Spain, Portugal
Erasmus Medical Center
Sanofi

Withdrawn

Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs (CARVE)

Prostatic Neoplasms

Netherlands
University Medical Center Groningen
Dutch Cancer Society

Recruiting

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (PERYTON)

Prostate Cancer | Cancer Recurrence

Netherlands
The Netherlands Cancer Institute
Bayer

Completed

Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223 (ROTOR)

Bone Metastases | Prostate Cancer Metastatic

Netherlands
Astellas Pharma Europe Ltd.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone (PRESIDE)

Metastatic Castration Resistant Prostate Cancer

Belgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Prostatic Neoplasms | Hormone-Refractory Prostate Cancer

United States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
European Organisation for Research and Treatment...

Completed

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases

Prostate Cancer | Metastatic Cancer

Netherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal

Clinical Trials on Males With Benign Prostatic Hyperplasia Symptoms in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations